European Association for the Study of Diabetes Annual Meeting 2021 (Virtual EASD 2021)

Automatic retinal image analysis identifies diabetes early with high sensitivity

Kanas Chan, 20211115000000

Screening of undiagnosed diabetes can be performed effectively with an automatic retinal image analysis (ARIA) technology developed by researchers at the Chinese University of Hong Kong (CUHK), instead of a finger-prink test.

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

Elaine Soliven, 20211029000000

The combination of bamlanivimab and etesevimab reduces the risk of COVID-19-related hospitalization and any-cause death in high-risk ambulatory patients, particularly those with diabetes, according to the BLAZE-1* study presented at EASD 2021.

High-dose semaglutide improves glucose metabolism outcomes in overweight/obese patients with T2D

Elaine Soliven, 20211027000000

Treatment with a higher dose of semaglutide led to significantly improved glucose metabolism outcomes in patients with overweight/obesity and type 2 diabetes (T2D) compared with a lower dose of semaglutide or placebo, according to the STEP* 2 trial presented at EASD 2021.

Men at greater risk of death after bariatric surgery than women

Mortality after bariatric surgery: More common in men than women?

Roshini Claire Anthony, 20211015180001

Mortality following bariatric surgery is rare but more common in men than women, according to a retrospective study from Austria presented at EASD 2021.

Common, cheap osteoporosis drug promising for T2D

Elvira Manzano, 20211014000000

The osteoporosis drug alendronate halves the risk of developing type 2 diabetes (T2D) in a nationwide, retrospective, case-control study of nearly 700,000 patients from Denmark.

fructose consumption tied to more liver fat

Fructose from fruit juice, SSBs tied to higher liver fat content

Audrey Abella, 20211013100000

The consumption of fructose from fruit juice and sugar sweetened beverages (SSBs), but not from fruit, is associated with higher intrahepatic lipid (IHL) content, according to data from a cross-sectional study presented at EASD 2021.

Older age, CRP portend deaths in COVID-19 patients with diabetes

Elvira Manzano, 20211013000000

Older age and elevated levels of the inflammatory marker C-reactive protein (CRP) may predict mortality in COVID-19 patients, particularly if coupled with diabetes, the retrospective ACCREDIT study has shown.

T1D: How close are we to a fully artificial pancreas?

Diabetes: How close are we to a fully artificial pancreas?

Pearl Toh, 20211009140100

A novel fully closed-loop system (fully artificial pancreas) delivering faster-acting insulin aspart (Fiasp) plus pramlintide achieved a high rate of glycaemic control among patients with type 1 diabetes (T1D) without the need for carbohydrate counting, according to a crossover noninferiority study presented at EASD 2021.

CV risk remains elevated in metabolically healthy obese

Roshini Claire Anthony, 20211008180001

Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.

Is liraglutide cardioprotective in T2D patients?

Audrey Abella, 20211006100000

In individuals with type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide appeared to yield a cardioprotective benefit, data from the secondary endpoint analysis of the LIRAFLAME* trial suggests.